acut
behav
interstiti
lung
diseas
ild
compris
sever
diseas
known
unknown
caus
common
featur
acut
manifest
appear
diffus
alveolar
damag
dad
lung
gener
associ
bad
prognosi
high
mortal
patient
acut
ild
may
rapidli
evolv
idiopath
nonidiopath
diseas
may
occur
first
symptom
may
repres
predilect
chronic
lung
diseas
altern
encount
acut
manifest
chronic
ild
pathogenet
mechan
underli
disord
acut
exacerb
larg
unknown
clinic
point
view
diagnost
treatment
patient
demand
sinc
addit
differenti
diagnost
mention
diagnost
procedur
exclud
infect
drug
reaction
diseas
cardiac
diseas
pulmonari
embol
clinic
manifest
resembl
acut
respiratori
distress
syndrom
ard
diffus
alveolar
hemorrhag
dah
acut
fibrin
organ
pneumonia
afop
moreov
nomenclatur
diseas
chang
past
decad
thu
uncommon
mani
specialist
exampl
pulmonologist
pathologist
radiologist
intens
care
specialist
may
refer
disord
differ
term
patient
suffer
aggress
ild
challeng
mani
specialist
least
pulmonologist
also
due
appear
unpredict
acut
diseas
exacerb
first
studi
dad
publish
year
ago
phenomenon
still
mysteri
one
first
studi
issu
cederberg
et
al
describ
hyalin
membran
autopsi
patient
receiv
oxygen
high
concentr
although
histolog
featur
dad
describ
even
earlier
name
diffus
alveolar
damag
dad
present
katzenstein
coauthor
comprehens
review
articl
includ
also
data
patient
dad
role
oxygen
shock
relat
factor
conclud
dad
nonspecif
reaction
lung
multitud
injuri
agent
endotheli
alveolar
cell
injuri
lead
fluid
cellular
exud
hyalin
membran
edema
wellknown
featur
year
later
askin
katzenstein
report
pneumocysti
infect
may
masquerad
dad
later
studi
reveal
autopsi
find
patient
acquir
immunodefici
syndrom
aid
dad
lung
cytomegaloviru
andor
pneumocysti
carinii
like
etiolog
one
first
immunohistochem
studi
issu
human
publish
studi
matsubara
coauthor
show
destruct
alveolar
basement
membran
dad
studi
matrix
metalloproteinas
mmp
tissu
inhibitor
timp
dad
idiopath
pulmonari
fibrosi
ipf
demonstr
factor
associ
myofibroblast
epitheli
cell
subsequ
studi
reveal
presenc
muscl
actin
posit
myofibroblast
prolif
phase
dad
hyalin
membran
patient
dad
show
heterogen
may
suggest
structur
might
form
differ
mechan
dad
variou
aetiolog
conclud
studi
histopatholog
pathogenesi
dad
human
lung
spars
far
littl
learnt
pathogenesi
review
articl
katzenstein
coauthor
publish
nearli
four
decad
ago
ipf
common
iip
account
interstiti
pneumonia
finland
preval
estim
common
male
age
year
femal
usual
progress
diseas
averag
surviv
year
diagnosi
efficaci
medic
treatment
current
avail
potenti
cure
may
lung
transplant
tabl
aggreg
fibroblast
myofibroblast
fibroblast
foci
ff
characterist
uip
even
though
cell
type
may
present
also
type
pulmonari
fibros
eg
cvd
asbestosi
lesser
extent
patient
experi
acut
exacerb
ae
concurr
dad
histopatholog
significantli
worsen
prognosi
prevent
predict
treat
ae
key
issu
longterm
followup
patient
unfortun
current
unresolv
nsip
describ
katzenstein
fiorelli
diseas
may
idiopath
although
common
type
interstiti
pneumonia
associ
mani
cvd
patient
nsip
usual
younger
counterpart
ipf
occur
often
women
men
children
may
also
suffer
nsip
idiopath
diseas
cvdassoci
diseas
nsip
may
progress
slowli
present
nonprogress
diseas
may
also
respond
corticosteroid
treatment
also
respect
differ
ipf
nsip
patient
still
aliv
year
diagnosi
nsip
divid
cellular
fibros
pattern
latter
may
resembl
ipf
clinic
cours
prognosi
histolog
nsip
usual
uniform
cellular
type
nsip
chronic
interstiti
inflammatori
cell
involv
alveolar
wall
wherea
fibrot
form
nsip
may
includ
advanc
fibrosi
prognosi
fibrot
type
nsip
dismal
problem
encount
includ
ae
dad
similar
describ
diseas
ipf
aip
firstli
describ
hamman
rich
mani
decad
patient
first
paper
assum
suffer
uipipf
fact
patient
shown
truli
suffer
aip
clinic
aip
present
rapid
develop
respiratori
failur
previous
healthi
person
clinic
radiolog
usual
display
featur
ard
contrast
ard
specif
caus
aetiolog
found
therefor
could
consid
idiopath
ard
figur
histolog
pattern
aip
typic
dad
hyalin
membran
edema
interstiti
acut
inflamm
organ
phase
dad
approxim
day
injuri
alveolar
septal
thicken
loos
organ
fibrosi
type
ii
pneumocyt
hyperplasia
patchi
diffus
airspac
organ
found
figur
c
prognosi
aip
dismal
mortal
high
suggest
adopt
aggress
diagnost
approach
mechan
ventil
lungprotect
strategi
earli
institut
immunosuppress
therapi
may
possibl
improv
clinic
outcom
aip
control
prospect
studi
treatment
aip
avail
surpris
sinc
aip
uncommon
gener
acut
lung
manifest
display
overlap
featur
ard
although
ipf
usual
relentlessli
progress
diseas
last
month
even
year
may
also
start
insidi
onset
display
ae
typic
featur
worsen
dyspnea
cough
lowgrad
fever
worsen
gasexchang
paramet
appear
new
opac
radiolog
condit
need
differenti
aip
patient
previou
lung
diseas
univers
accept
diagnost
criteria
ae
ipf
although
criteria
propos
kondoh
akira
kim
recent
ipf
clinic
research
network
investig
tabl
worsen
dyspnoea
within
one
month
deterior
gasexchang
paramet
combin
exclus
heart
diseas
pulmonari
embol
infect
tabl
recent
studi
show
oneyear
threeyear
incid
ae
ipf
respect
etiolog
ae
ipf
unknown
although
publish
case
report
propos
bronchoalveolar
lavag
bal
lung
biopsi
procedur
certain
drug
treatment
might
trigger
ae
ipf
patient
recent
studi
claim
patient
ipf
presenc
ongo
ae
time
lung
biopsi
surgeri
repres
mark
risk
factor
complic
mortal
circul
fibrocyt
shown
elev
patient
stabl
ipf
increas
occur
ae
ipf
wherea
patient
ard
differ
healthi
control
subject
stabl
patient
ipf
anoth
recent
studi
observ
total
gene
differenti
express
stabl
ipf
ae
ipf
howev
function
analysi
gene
reveal
evid
infecti
inflammatori
aetiolog
overal
result
obtain
gene
express
profil
identifi
epitheli
injuri
prolifer
key
molecular
genet
event
ae
propos
plasma
defensin
could
consid
new
biomark
acut
diseas
exacerb
quit
recent
studi
collard
coauthor
interestingli
show
plasma
patient
ae
ipf
show
signific
elev
marker
type
ii
alveolar
epitheli
cell
injuri
andor
prolifer
endotheli
cell
injuri
coagul
moreov
profil
differ
biomark
profil
patient
acut
lung
injuri
ae
ipf
present
radiolog
chang
addit
typic
ipfalter
especi
lower
lung
includ
peripher
predomin
basal
predomin
reticular
abnorm
honeycomb
traction
bronchiectasi
bronchiolectasi
akira
coauthor
studi
ipfpati
ae
two
radiologist
evalu
featur
highresolut
comput
tomographi
hrct
evalu
overal
extent
parenchym
chang
consolid
reticul
honeycomb
note
hrct
chang
classifi
three
type
name
peripher
multifoc
diffus
pattern
particular
studi
show
ae
process
radiolog
hrct
chang
may
vari
peripher
pattern
common
phenomenon
conclus
radiolog
studi
appear
shortest
surviv
ae
ipf
associ
diffus
abnorm
hrct
base
systemat
review
publish
studi
rather
small
number
ipf
patient
ae
case
men
year
whose
lung
function
test
rel
good
suggest
clinic
cours
diseas
earli
phase
nearli
patient
display
neutrophilia
bal
fluid
ground
glass
opac
consolid
hrct
importantli
biopsi
case
present
dad
superimpos
uip
lung
histopatholog
prognosi
ae
poor
mechan
invas
noninvas
treat
group
sinc
patient
die
within
one
month
ae
despit
activ
medic
treatment
present
consensu
treatment
ae
ipf
although
patient
receiv
therapi
corticosteroid
immunosuppress
drug
one
studi
evalu
use
pirfenidon
patient
ipf
termin
prematur
placebocontrol
group
patient
suffer
ae
occur
pirfenidon
group
indic
drug
might
efficaci
prevent
ae
ipf
suggest
need
confirm
futur
therapeut
conclus
drawn
effort
recogn
predict
exacerb
earli
possibl
major
signific
overal
treatment
patient
includ
possibl
lung
transplant
addit
ipf
ae
shown
occur
type
ild
base
one
studi
patient
idiopath
nsip
patient
cvd
ild
ae
occur
six
patient
idiopath
nsip
four
patient
cvdild
rheumatoid
arthriti
scleroderma
studi
ae
diagnos
akira
criteria
two
case
took
place
immedi
surgic
lung
biopsi
lung
biopsi
find
show
dad
addit
nsip
anoth
recent
studi
examin
patient
surgic
lung
biopsi
proven
fibrot
hypersensit
pneumon
allerg
alveol
experienc
acut
declin
respiratori
statu
met
criteria
similar
propos
diagnosi
ae
ipf
patient
experienc
clinic
cours
similar
ae
ipf
case
result
either
death
patient
lung
transplant
lung
biopsi
time
ae
autopsi
reveal
organ
dad
superimpos
fibrot
lung
diseas
recent
studi
biopsi
patient
cvd
ild
five
patient
suffer
rheumatoid
arthriti
one
patient
scleroderma
associ
either
uip
nsip
unclassifi
ild
chang
ae
five
patient
die
despit
activ
treatment
includ
invas
mechan
ventil
immunosuppress
medic
prognosi
patient
cvd
gener
significantli
better
compar
ipf
howev
conclud
ae
interstiti
lung
diseas
exhibit
similar
clinic
radiolog
histolog
find
need
emphas
also
lung
manifest
system
diseas
complex
therefor
need
evalu
care
develop
dad
still
poorli
understood
treatment
empir
sever
studi
indic
ipf
patient
acut
lung
failur
benefit
intens
care
treatment
invas
mechan
ventil
also
propos
invas
mechan
ventil
use
patient
schedul
undergo
lung
transplant
oper
within
day
ild
patient
experi
acut
lung
failur
mani
possibl
caus
consid
diagnost
exampl
deterior
chronic
lung
diseas
infect
ae
diseas
drug
reaction
recent
guidelin
publish
british
thorac
societi
recommend
palli
treatment
patient
ae
ipf
wherea
ild
revers
need
diagnos
treat
activ
thu
revers
ild
acut
respiratori
failur
treat
intens
care
treatment
mechan
ventil
thu
bal
transbronchi
biopsi
surgic
lung
biopsi
consid
diagnost
procedur
taken
togeth
current
invasiveintens
treatment
definit
role
ae
ipf
intens
treatment
method
extens
diagnost
consid
acut
exacerb
ild
howev
realiti
often
difficult
exclud
infect
ipf
patient
experienc
acut
deterior
therefor
care
consider
need
especi
patient
may
benefit
lung
transplant
oper
lung
biopsi
procedur
mechan
ventil
patient
previous
assum
carri
high
risk
patient
thu
recommend
howev
recent
studi
indic
lung
biopsi
oper
rel
safe
shown
rather
secur
procedur
even
mechan
ventil
patient
lim
coauthor
studi
mechan
ventil
patient
undiagnos
diffus
pulmonari
infiltr
undergon
open
lung
biopsi
procedur
diagnost
purpos
common
find
lung
biopsi
iip
aip
common
type
occur
patient
three
patient
ae
ipf
addit
interstiti
pneumonia
singl
case
infect
drug
reaction
also
observ
common
complic
prolong
air
leakag
occur
fifteen
patient
none
complic
fatal
lung
biopsi
find
chang
treatment
patient
open
lung
biopsi
conduct
within
one
week
initi
mechan
ventil
improv
prognosi
surviv
patient
conclud
lung
biopsi
recommend
even
ventil
patient
care
consider
accur
diagnosi
like
contribut
treatment
ashbaugh
coauthor
describ
patient
acut
respiratori
distress
new
definit
lung
injuri
recommend
patient
separ
two
group
name
patient
less
sever
hypoxemia
classifi
acut
lung
injuri
ali
sever
hypoxemia
suffer
ard
common
morpholog
pattern
ard
dad
featur
correl
better
phase
alveolar
damag
specif
caus
anoth
histolog
pattern
clinic
radiolog
express
ard
afop
pattern
meet
strict
histolog
criteria
either
organ
pneumonia
op
dad
prognosi
afop
better
dad
dad
divid
exud
prolif
fibrot
organ
phase
patholog
alter
seen
ard
howev
shown
heterogen
sinc
recent
studi
half
patient
ard
display
typic
dad
postmortem
examin
hand
less
half
patient
postmortem
autopsi
find
dad
treat
intens
care
unit
diagnos
clinic
ard
signific
differ
ard
aip
support
larg
differ
dad
lung
ard
patient
known
etiolog
trigger
ard
aip
factor
may
account
variabl
patient
recoveri
retrospect
studi
patient
dad
lung
histopatholog
reveal
immunocompromis
fulfil
ard
criteria
time
lung
biopsi
caus
dad
particular
studi
infect
aip
noninfecti
complic
organ
stem
cell
transplant
cvd
ae
ipf
drug
reaction
radiat
therapi
overal
mortal
lung
diseas
except
ae
ipf
mortal
higher
histolog
dad
abl
reveal
caus
alveolar
damag
although
recent
studi
depict
two
form
dad
patient
ard
show
interstiti
myofibroblast
prolifer
common
patient
chemotherapi
drug
toxic
sever
infect
clinic
point
view
import
understand
histolog
pattern
dad
nonspecif
lung
reaction
provid
inform
clinician
reason
diseas
sepsi
trauma
aspir
infect
drug
associ
idiopath
diseas
aip
dad
common
lung
reaction
patient
suffer
influenza
infect
landmark
paper
goodpastur
coauthor
describ
autopsi
find
two
patient
suffer
influenza
case
lung
show
featur
dad
includ
hyalin
materi
upon
wall
dilat
alveolar
duct
alveoli
typic
histolog
pattern
dad
particular
paper
state
present
lesion
lung
regard
peculiar
pulmonari
inflamm
influenza
yet
microorgan
demonstr
usual
method
lung
either
avian
influenza
viru
infect
sever
acut
respiratori
syndrom
sar
dad
common
autopsi
find
lung
recent
studi
describ
autopsi
find
patient
infect
age
patient
vari
year
year
twenti
patient
dad
lung
addit
dad
lung
patient
exhibit
also
necrot
bronchiol
five
patient
display
extens
hemorrhag
overal
extens
manifest
observ
lung
risk
develop
dad
sever
studi
decad
ago
also
suggest
role
viral
infect
pathogenesi
ipf
virus
includ
hepat
c
ebstein
barr
cytomegalo
herp
viral
infect
interestingli
recent
studi
vannella
cowork
hypothes
gammaherp
virus
serv
initi
cofactor
pathogenesi
pulmonari
fibrosi
even
ae
line
new
find
recent
studi
identifi
candid
gene
ipf
regul
antivir
respons
highli
like
role
viral
infect
etiolog
pathogenesi
ipf
interstiti
lung
diseas
ae
may
import
previous
assum
sever
idiopath
nonidiopath
interstiti
lung
diseas
display
similar
morpholog
featur
name
dad
either
stabl
phase
especi
exacerb
diseas
tabl
ipf
nsip
cvdild
allerg
alveol
acut
exacerb
may
occur
typic
histolog
featur
diseas
superimpos
dad
patholog
addit
iip
includ
aip
clinic
ard
also
dad
diseas
patholog
featur
moreov
seriou
manifest
influenza
viral
infect
dad
reaction
within
lung
recent
studi
suggest
virus
may
play
role
ipf
exacerb
thu
seem
mani
way
dad
reaction
lung
may
trace
mani
caus
therefor
might
assum
repres
seriou
nonspecif
reaction
respons
varieti
trigger
mani
factor
pathogenesi
dad
remain
still
unresolv
one
could
understand
mechan
underli
dad
reaction
might
possibl
use
novel
inform
develop
improv
treatment
mani
lung
diseas
today
untreat
one
major
find
reaction
injuri
alveolar
epithelium
therefor
therapeut
strategi
aim
protect
epithelium
may
repres
novel
strategi
care
evalu
futur
evid
interstiti
lung
diseas
repres
heterogen
group
lung
diseas
includ
lung
diseas
known
reason
allerg
alveol
connect
tissu
diseas
associ
lung
diseas
infecti
lung
disord
acut
reaction
within
lung
may
similar
name
dad
reaction
postul
repres
one
fundament
injuri
respons
lung
howev
pathogenet
mechan
underli
dad
still
mostli
unknown
especi
human
experiment
studi
conduct
anim
expos
toxin
lipopolysaccharid
forth
reaction
directli
extrapol
human
lung
sinc
lung
reaction
occur
mice
rat
resembl
exactli
encount
human
lung
anoth
limit
studi
dad
human
lung
rariti
diseas
difficult
virtual
imposs
gather
larg
number
patientssampl
dadassoci
lung
diseas
acut
exacerb
without
intern
collabor
involv
sever
special
argu
studi
dadassoci
lung
diseas
even
difficult
iip
type
rel
rare
lung
diseas
dad
confin
unpredict
period
variou
diseas
systemat
collect
human
lung
tissu
cell
materi
would
significantli
improv
clinicalradiologicalhistopatholog
interpret
especi
combin
experiment
vitro
studi
cell
establish
human
lung
method
studi
diseas
mechan
dramat
develop
last
decad
older
statement
conclus
may
requir
new
interpret
reevalu
exampl
recent
evid
suggest
virus
may
play
import
role
aetiolog
pathogenesi
ild
also
exacerb
virus
directli
caus
dad
reaction
lung
need
intern
effort
collabor
studi
dadassoci
lung
diseas
discov
target
therapi
sinc
diseas
uncommon
prognosi
patient
dismal
year
still
poor
patient
evalu
treat
mani
special
